NOAH ZINKIN: Open Payments
NPI 1619908217 · HUNTINGTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$33,438 in 173 payments from 25 companies in 2025. Trend: 2023 $9,425 · 2024 $19,316 · 2025 $33,438
Speaker / faculty: $29,763Food & beverage: $3,655Education: $20
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $19,077 |
| ABBVIE INC. | 42 | $11,991 |
| Madrigal Pharmaceuticals | 10 | $371 |
| Lilly USA, LLC | 14 | $324 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $280 |
| Janssen Biotech, Inc. | 14 | $257 |
| PFIZER INC. | 13 | $246 |
| QOL Medical, LLC | 6 | $196 |
| Ardelyx, Inc. | 7 | $129 |
| Aimmune Therapeutics, Inc. | 3 | $68 |
Products named: ENTYVIO, SKYRIZI, RINVOQ, REZDIFFRA, OMVOH, XIFAXAN, TREMFYA, Sucraid.
Industry payments across NY — which companies pay providers there.
